Risperidone-induced tardive dyskinesia.
Bassitt
D P
DP
Instituto de Psiquiatria do Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Brasil. dbassit@amcham.com.br
de Souza Lobo Garcia
L
L
D000328:Adult; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001712:Biperiden / Q000627:therapeutic use; D001764:Blepharospasm / Q000139:chemically induced / Q000188:drug therapy; D001905:Botulinum Toxins / Q000627:therapeutic use; D002998:Clonazepam / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy / Q000209:etiology*; D004569:Electroencephalography; D006801:Humans; D008297:Male; D018967:Risperidone / Q000009:adverse effects*; D012563:Schizophrenia, Paranoid / Q000188:drug therapy*
D018726:Anti-Dyskinesia Agents; D014150:Antipsychotic Agents; D001712:Biperiden; D002998:Clonazepam; D001905:Botulinum Toxins; D018967:Risperidone